Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, Matsui K, Shiono H, Okumura M, Nishida T, Tachibana I, Norioka N, Norioka S, Kawase I. He P, et al. Among authors: kawase i. Cancer Sci. 2007 Aug;98(8):1234-40. doi: 10.1111/j.1349-7006.2007.00509.x. Epub 2007 May 15. Cancer Sci. 2007. PMID: 17506794 Free PMC article.
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
Iwahori K, Osaki T, Serada S, Fujimoto M, Suzuki H, Kishi Y, Yokoyama A, Hamada H, Fujii Y, Yamaguchi K, Hirashima T, Matsui K, Tachibana I, Nakamura Y, Kawase I, Naka T. Iwahori K, et al. Among authors: kawase i. Lung Cancer. 2008 Oct;62(1):45-54. doi: 10.1016/j.lungcan.2008.02.012. Epub 2008 Apr 3. Lung Cancer. 2008. PMID: 18394747
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
Oji Y, Kitamura Y, Kamino E, Kitano A, Sawabata N, Inoue M, Mori M, Nakatsuka S, Sakaguchi N, Miyazaki K, Nakamura M, Fukuda I, Nakamura J, Tatsumi N, Takakuwa T, Nishida S, Shirakata T, Hosen N, Tsuboi A, Nezu R, Maeda H, Oka Y, Kawase I, Aozasa K, Okumura M, Miyoshi S, Sugiyama H. Oji Y, et al. Among authors: kawase i. Int J Cancer. 2009 Jul 15;125(2):381-7. doi: 10.1002/ijc.24367. Int J Cancer. 2009. PMID: 19384943
Proteomic analysis of autoantigens associated with systemic lupus erythematosus: Anti-aldolase A antibody as a potential marker of lupus nephritis.
Serada S, Fujimoto M, Takahashi T, He P, Hayashi A, Tanaka T, Hagihara K, Yamadori T, Mochizuki M, Norioka N, Norioka S, Kawase I, Naka T. Serada S, et al. Among authors: kawase i. Proteomics Clin Appl. 2007 Feb;1(2):185-91. doi: 10.1002/prca.200600497. Epub 2007 Jan 22. Proteomics Clin Appl. 2007. PMID: 21136668
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
Kijima T, Takeuchi K, Tetsumoto S, Shimada K, Takahashi R, Hirata H, Nagatomo I, Hoshino S, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I. Kijima T, et al. Among authors: kawase i. Cancer Sci. 2011 Aug;102(8):1602-4. doi: 10.1111/j.1349-7006.2011.01970.x. Cancer Sci. 2011. PMID: 21767331 Free article.
Serum HE4 as a diagnostic and prognostic marker for lung cancer.
Iwahori K, Suzuki H, Kishi Y, Fujii Y, Uehara R, Okamoto N, Kobayashi M, Hirashima T, Kawase I, Naka T. Iwahori K, et al. Among authors: kawase i. Tumour Biol. 2012 Aug;33(4):1141-9. doi: 10.1007/s13277-012-0356-9. Epub 2012 Feb 29. Tumour Biol. 2012. PMID: 22373583
319 results